Your browser doesn't support javascript.
loading
Emergence of a BCR::ABL1 rearrangement following a uniquely complex clonal evolution pattern in a patient undergoing Fms-like tyrosine kinase 3 inhibitor therapy for acute myeloid leukemia.
Park, Bosung; Kim, Jiyeon; Kim, Miyoung; Cho, Young-Uk; Hwang, Sang-Hyun; Jang, Seongsoo; Seo, Eul-Ju; Choi, Eun-Ji; Park, Chan-Jeoung.
Afiliação
  • Park B; Department of Laboratory Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim J; Department of Laboratory Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Kim M; Department of Laboratory Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Cho YU; Department of Laboratory Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Hwang SH; Department of Laboratory Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Jang S; Department of Laboratory Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Seo EJ; Department of Laboratory Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Choi EJ; Department of Hematology, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
  • Park CJ; Department of Laboratory Medicine, Asan Medical Centre, University of Ulsan College of Medicine, Seoul, South Korea.
Int J Lab Hematol ; 45(2): e24-e27, 2023 04.
Article em En | MEDLINE | ID: mdl-36180046

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Tirosina Quinase 3 Semelhante a fms / Evolução Clonal / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Leucemia Mieloide Aguda / Tirosina Quinase 3 Semelhante a fms / Evolução Clonal / Antineoplásicos Limite: Humans Idioma: En Ano de publicação: 2023 Tipo de documento: Article